蛋白激酶D(PKD)抑制剂(PKD2,PKD3和PKD1的IC50值分别为0.6、0.7和3.2μM)。细胞可渗透性(对于PKD1抑制,EC50 =10μM)。ATP具有竞争力。CID-2011756 is a cell-active ATP competitive and specific PKD1 inhibitor that inhibits phorbol ester-induced endogenous PKD1 activation in LNCaP prostate cancer cells.
Solvent:DMSO, Max Conc. mg/mL: 19.84, Max Conc. mM: 50;≥39.7 mg/mL in DMSO with gentle warming; insoluble in H2O; ≥2.34 mg/mL in EtOH with gentle warming and ultrasonic
分子量
396.900 g/mol
XLogP3
3.900
氢键供体数Hydrogen Bond Donor Count
1
氢键受体数Hydrogen Bond Acceptor Count
4
可旋转键计数Rotatable Bond Count
5
精确质量Exact Mass
396.124 Da
单同位素质量Monoisotopic Mass
396.124 Da
拓扑极表面积Topological Polar Surface Area
54.700 Ų
重原子数Heavy Atom Count
28
形式电荷Formal Charge
0
复杂度Complexity
506.000
同位素原子数Isotope Atom Count
0
定义的原子立体中心计数Defined Atom Stereocenter Count
0
未定义的原子立体中心计数Undefined Atom Stereocenter Count
0
定义的键立体中心计数Defined Bond Stereocenter Count
0
未定义的键立体中心计数Undefined Bond Stereocenter Count
0
所有立体化学键的总数The total count of all stereochemical bonds